Creative Peptides Sweden AB

Creative Peptides is a biopharmaceutical company with the mission to bring products to the market that will significantly improve on the treatment and prevention of long-term complications of diabetes, which are currently not effectively and safely treatable.

The first product in development, currently in phase IIb development, is an innovative and safe long-term hormone replacement therapy for diabetes neuropathy, based on recombinant human C-peptide.

Approximately 3 million patients could potentially benefit from life-long daily treatment with C-peptide. With indication extended to prevention of type 1 diabetes complications, 10-14 million patients could potentially benefit.